Top Abstract Purchase Related
Home
>
Node
>
Subnode

Establishing requirements for the use of terms for reporting adverse drug reactions

Venulet, J.

International Journal of Clinical Pharmacology Research 12(2): 61-64

1992

ISSN/ISBN: 0251-1649
PMID: 1428299
Document Number: 395770
The establishment of a project for the standardization of international reporting of adverse drug reactions (ADR), sponsored by the Council for International Organizations of Medical Sciences is described. The need to establish requirements for properly diagnosing a given suspected ADR and to describe it with the correct terms is demonstrated. However in view of the difficulties involved, it is suggested that the present deliberate approach needs to be reconsidered.

Document emailed within 1 workday
Secure & encrypted payments

Homma, M. 1992: Adverse events and adverse reactions associated with drugs--important actual spontaneous reporting of the drug event Ryumachi 32(5): 429-431
Soletsky, L.M. 1997: Reporting of adverse drug reactions Postgraduate Medicine 102(1): 35-36
Kimelblatt, B.J.; Young, S.H.; Heywood, P.M.; Mandala, A.R.; Gendelman, S.; Mehl, B. 1988: Improved reporting of adverse drug reactions American Journal of Hospital Pharmacy 45(5): 1086-1089
Bégaud, B.; Martin, K.; Haramburu, Fçoise.; Moore, N. 2002: Rates of spontaneous reporting of adverse drug reactions in France JAMA 288(13): 1588
Ciorciaro, C.; Hartmann, K.; Kuhn, M. 1998: Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center) Schweizerische Medizinische Wochenschrift 128(7): 254-258
Kalaiselvan, V.; Prasad, T.; Bisht, A.; Singh, S.; Singh, G.Nath. 2014: Adverse drug reactions reporting culture in Pharmacovigilance Programme of India Indian Journal of Medical Research 140(4): 563-564
Schetz, D.; Sein Anand, J. 2015: Physician attitudes toward the reporting of adverse drug reactions on the Pomeranian region Przeglad Lekarski 72(9): 475-478
Gram, L.F. 1995: Attitude and considerations of Danish physicians towards reporting of adverse drug reactions--a questionnaire study under European direction Ugeskrift for Laeger 157(12): 1692-1694
Schumock, G.T.; Thornton, J.P.; Witte, K.W. 1991: Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions American Journal of Hospital Pharmacy 48(9): 1974-1976
Roeser, H.P.; Rohan, A.P. 1990: Post-marketing surveillance of drugs. The spontaneous reporting scheme: role of the Adverse Drug Reactions Advisory Committee Medical Journal of Australia 153(11-12): 720-726
Sui, M.; Cui, L. 2017: Constructing a Gene-Drug-Adverse Reactions Network and Inferring Potential Gene-Adverse Reactions Associations Using a Text Mining Approach Studies in Health Technology and Informatics 245: 531-535
Yang, Y-Yin.; Dong, Z.; Xia, Y-Peng. 2012: Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring Zhongguo Zhong Yao Za Zhi 37(21): 3329-3333
Gao, G.Fu. 2014: Implementing immunization program efficiently, and establishing national database of adverse reactions Science China. Life Sciences 57(5): 553-554
Wang, D.; Du, X-Xi. 2012: Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring Zhongguo Zhong Yao Za Zhi 37(18): 2686-2688
Hemmingsen, B.; Støy, L.; Wetterslev, Jørn.; Tarnow, L.; Friis, K.Bach.; Christensen, L.Lundby.; Sales, N.; Gluud, C.; Madsbad, S.; Snorgaard, O.; Røder, M.; Thorsteinsson, B.; Gade-Rasmussen, B.; Jarløv, A.; Sneppen, S.; Duun, E.; Jensen, T.; Mathiesen, E.; Perrild, H.; Krarup, T.; Vestergaard, H.; Nielsen, F.; Hedetoft, C.; Breum, L.; Christensen, L.Lundby.; Lund, Søren.S.; Boesgaard, T.W.; Tarnow, L.; Pedersen, O.; Vaag, A.; Almdal, T.; Hemmingsen, B.; Wetterslev, Jørn.; Gluud, C.; Hansen, B.Visbøll.; Rosenfeldt, M.; Salas, N. 2010: Reporting adverse reactions and events in randomised clinical trials Ugeskrift for Laeger 172(35): 2381-2384
Bernstein, J.A. 1995: Nonimmunologic adverse drug reactions. how to recognize and categorize some common reactions Postgraduate Medicine 98(1): 120-122; 125-126
Juergens, J.P.; Banahan, B.F. 1986: Adverse drug reaction reporting by Mississippi physicians Journal of the Mississippi State Medical Association 27(2): 33-37
Nelson, R.W.; Shane, R. 1983: Developing an adverse drug reaction reporting program American Journal of Hospital Pharmacy 40(3): 445-446
Kaplan, A.S. 1984: Adverse drug reaction reporting and the family physician Journal of Family Practice 19(4): 563-564
Davidson, K.W.; Kahn, A.; Price, R.D. 1987: Reduction of adverse drug reactions by computerized drug interaction screening Journal of Family Practice 25(4): 371-375